首页 › 基金 › Atle Fund Management AB › BCAX
Atle Fund Management AB 对 BCAX 的持仓历史
BICARA THERAPEUTICS INC · 医疗保健
Atle Fund Management AB 在 Q2 2026 的 13F 申报中披露持有 BCAX(BICARA THERAPEUTICS INC)145,657 股,市值约 US$4.3M,约占其申报组合的 1.16%,在其申报持仓中市值排名第 33 位。 Atle Fund Management AB 最近 6 个申报季度中有 6 个季度披露了 BCAX 持仓,最早可追溯至 Q1 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Atle Fund Management AB 对 BCAX 的持仓演变
Atle Fund Management AB 于 Q1 2025 首次披露 BCAX 持仓:119,833 股(约 US$1.6M)。 该持仓在 Q2 2026 达到峰值 145,657 股,市值约 US$4.3M。 在 6 次申报中,Atle Fund Management AB 3 次增持、2 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 145,657 股、市值约 US$4.3M,环比减持 -1,023,977 股。。 持仓曾出现大幅变动:Q4 2025 减持约 45% (随后一个季度股价上涨 18%)、Q1 2026 增持约 950% (随后一个季度股价上涨 49%)、Q2 2026 减持约 88% (随后一个季度股价下跌 37%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2025 | 119.83K | $1.56M | 新进 |
| Q2 2025 | 147.38K | $1.37M | 增持 |
| Q3 2025 | 203.75K | $341.56K | 增持 |
| Q4 2025 | 111.36K | $1.87M | 减持 |
| Q1 2026 | 1.17M | $2.32M | 增持 |
| Q2 2026 | 145.66K | $4.32M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BCAX 与 13F 数据
BCAX(BICARA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 58 只申报持有 BCAX,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$215.4M), Siren, L.L.C. (US$166.4M), Vestal Point Capital, LP (US$155.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BCAX 的基金
- RA CAPITAL MANAGEMENT, L.P. 7.26M 股 · $215.43M · Q2 2026
- Siren, L.L.C. 5.60M 股 · $166.35M · Q2 2026
- Vestal Point Capital, LP 5.25M 股 · $155.87M · Q2 2026
- Deep Track Capital, LP 4.10M 股 · $121.73M · Q2 2026
- TPG GP A, LLC 3.01M 股 · $89.38M · Q2 2026
- Red Tree Management, LLC 2.92M 股 · $54.35M · Q3 2026
- Omega Fund Management, LLC 1.82M 股 · $54.10M · Q2 2026
- Jones Hill Capital LP 892.62K 股 · $26.50M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 643.38K 股 · $19.10M · Q2 2026
- Aisling Capital Management LP 568.92K 股 · $16.89M · Q2 2026
- Palo Alto Investors LP 550.41K 股 · $16.34M · Q2 2026
- Rock Springs Capital Management LP 535.29K 股 · $15.89M · Q2 2026
更多关于 Atle Fund Management AB
常见问题
How long has Atle Fund Management AB held BCAX?
Atle Fund Management AB has disclosed BCAX holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Atle Fund Management AB's current position in BCAX?
As of Q2 2026, Atle Fund Management AB holds 145.66K shares of BCAX (BICARA THERAPEUTICS INC), valued at $4.32M, representing 1.16% of its reported portfolio and ranking #33.
Has Atle Fund Management AB been buying or selling BCAX?
In the latest 13F filing (Q2 2026), Atle Fund Management AB reduced its position in BCAX. The position peaked in Q2 2026 at 145.66K shares.
Which other funds hold BCAX?
Other major institutional holders of BCAX include RA CAPITAL MANAGEMENT, L.P., Siren, L.L.C., Vestal Point Capital, LP, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.